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The Journal of Immunology ADAM17 Activity and Other Mechanisms of Soluble L-selectin Production during Death Receptor-Induced Leukocyte Apoptosis Yue Wang, Adam C. Zhang, Zhenya Ni, Amy Herrera, and Bruce Walcheck L-selectin is an adhesion molecule expressed by neutrophils that broadly directs their infiltration in to sites of inflammation. It is also present at relatively high levels in the serum of normal individuals. It is well established that L-selectin is efficiently shed from the surface of neutrophils upon their activation, a process that regulates its density and binding activity. Neutrophil programmed cell death is critical for the resolution of inflammation, and L-selectin downregulation is induced during this process as well. The mechanisms underpinning this latter process are much less understood, and were investigated in this study. Using a disintegrin and metalloprotease (ADAM)-17 radiation chimeric mice, we demonstrate for the first time that during early events of death receptor-mediated neutrophil apoptosis, L-selectin downregulation occurs primarily by ADAM17-mediated shedding. This was observed as well upon using shRNA to knock down ADAM17 expression in Jurkat cells, a well-studied cell line in terms of the molecular processes involved in the induction of apoptosis. These findings directly reveal that ADAM17 activity occurs during programmed cell death. Hence, the cleavage of particular ADAM17 substrates may be an additional component of the anti-inflammatory program initiated by apoptotic neutrophils. Of interest was that during later stages of induced leukocyte apoptosis, soluble L-selectin production occurred independent of ADAM17, as well as membrane events, such as blebbing and microparticle production. This process may provide an explanation for the lack of diminished serum L-selectin levels in ADAM17-null mice, and suggests a mechanism for the homeostatic maintenance of soluble L-selectin levels in the blood of healthy individuals. The Journal of Immunology, 2010, 184: 000-000. E ctodomain shedding is a regulated proteolytic process that directs the cleavage of cell surface proteins, typically at a juxta-membrane site, resulting in the release of a soluble extracellular domain fragment (1) (2) (3) . The functional implications of ectodomain shedding are diverse, because it can promote an immediate and prolonged formation of soluble agonists and antagonists, as well as regulate the density of receptors and adhesion molecules. The majority of a growing list of shed proteins are cleaved by a disintegrin and metalloprotease (ADAM)-17 (4) . Leukocytes express ADAM17, and a number of their products undergo ectodomain shedding (5) . By directly examining leukocytes that are deficient in functional ADAM17, it has been reported that this sheddase cleaves various inflammation regulating factors, including the pleiotropic cytokine TNFa, its two receptors TNFRI (CD120a) and TNFRII (CD120b), and L-selectin (CD62L) (6) (7) (8) (9) (10) (11) .
The enzymatic activity of ADAM17 is inducible, and its function has been primarily studied in the context of cell activation (12) (13) (14) . The leukocyte-expressed adhesion molecule L-selectin is perhaps one of the best characterized shed molecules in terms of structure and function analyses and its targeting by ADAM17 (8, (14) (15) (16) (17) (18) ; therefore, it is an excellent model protein for studying ADAM17 activity in leukocytes. L-selectin is constitutively expressed at high levels by resting neutrophils, and essentially all molecules are cleaved within minutes of neutrophil activation by a variety of physiological stimuli (19) .
In addition to their proinflammatory role during activation, neutrophils mediate an anti-inflammatory program upon programmed cell death (20, 21) , which includes an efficient downregulation of cell surface L-selectin expression (22, 23) . In our study, we directly examined the role of ADAM17 in this process by using leukocytes that lack expression of the sheddase. Our findings show that during early events of induced neutrophil apoptosis, L-selectin downregulation occurs primarily by ADAM17-mediated ectodomain shedding, indicating ADAM17 activity during the anti-inflammatory program. We also report that at later time points of induced neutrophil apoptosis, soluble L-selectin production can occur in a manner independent of ADAM17. This process may be important for regulating the high levels of soluble L-selectin in the blood of healthy individuals, thus providing a potential anti-adhesive environment.
Materials and Methods

Abs and other reagents
The anti-human L-selectin mAb DREG-200 has been previously described (24) . The anti-L-selectin mAb LAM1-116 (detects both murine and human L-selectin) conjugated to PE, biotin, or allophycocyanin, and recombinant human Fas ligand were purchased from Ancell (Bayport, MN). PE-conjugated anti-mouse LFA-1 (CD11a/CD18) mAb, PE-and allophycocyanin-conjugated anti-mouse L-selectin (Ly-22) mAb, and Alexa Fluor-488 anti-mouse Ly-6G (Gr-1) were purchased from eBioscience (San Diego, CA). The anti-human LFA-1 (CD11a/CD18) mAb R3.1 has been previously described (25) . The anti-Fas IgM mAb CH-11 was purchased from Upstate (Lake Placid, NY). The anti-ADAM10 and ADAM17 mAbs (clones 163003 and 111623, respectively) and TNFa were purchased from R&D Systems (Minneapolis, MN). Biotin, FITC-, PE-, and allophycocyanin-conjugated F(ab9) 2 goat antimouse IgG secondary Abs and allophycocyanin-conjugated streptavidin were purchased from Jackson Immunoresearch (West Grove, PA). DMEM, RPMI 1640, PBS, HBSS, HEPES, and molecular-grade water were purchased from Mediatech (Hevdon, VA). FBS was purchased from Atlas Biologicals (Fort Collins, CO). Penicillin-streptomycin solution was purchased from Cellgro (Manassas, VA). PMA was purchased from SigmaAldrich (St. Louis, MO). TAPI-1 was purchased from Peptides International (Louisville, KY). Leupeptin, 6-aminocaproic acid, APMSF-HCl, aprotinin, pepstatin A, and chymostatin were all purchased from Sigma-Aldrich. For cell apoptosis detection, a fluorescent-labeled inhibitor of caspases (FLICA) Poly Caspase kit (FAM-VAD-FMK) was purchased from ImmunoChemistry Technologies (Bloomington, MN), and FITC-and PE-conjugated annexin-V was purchased from BD Pharmingen (San Diego, CA).
Mice
All experimental procedures were performed in accordance with protocols approved by the Animal Care and Use Committee of the University of Minnesota. ADAM17 deficiency in mice is lethal between embryonic day 17.5 and soon after birth (7), and therefore radiation chimeric mice were generated by reconstitution with embryonic day 15-16, liver hematopoietic cells that either lacked or expressed functional ADAM17, as previously described (8, 9) . These mice are referred to as either ADAM17 chimeric or wild-type chimeric mice, respectively. ADAM8 knockout mice were provided by Dr. Andy J.P. Docherty (Celltech R&D, Slough, U.K.) via Dr. Carl P. Blobel (Hospital for Special Surgery, Weill Medical College of Cornell University) (26) . Age-matched mice were used for all experiments.
Cell culture, transduction, and induction of cellular apoptosis
All reagents used for cell isolation and incubations were sterile and tested for endotoxin. Cell viabilities were assessed by exclusion of the vital dye trypan blue. Mouse bone marrow neutrophils were isolated as previously described (8, 9) . For neutrophil treatments, cells were suspended in PBS at the indicated concentrations and initially equilibrated to culture conditions at 37˚C in 5% CO 2 . Some cell samples were incubated with the broadspectrum zinc metalloprotease inhibitor TAPI (50 nM) for 30 min, and then were treated with TNFa (5 mg/ml) with or without cycloheximide (35 mM) for the indicated time points. Jurkat cells (an acute T cell leukemia cell line) were maintained in DMEM/F12 supplemented with 8% heatinactivated FBS and antibiotics at 37˚C in 5% CO 2 . For Jurkat cell treatments, cells were suspended in RPMI 1640 at the indicated concentrations and initially equilibrated to culture conditions at 37˚C in 5% CO 2 . Some cell samples were incubated with TAPI (50 nM) for 30 min and treated with PMA (25 ng/ml), recombinant human FasL, or anti-Fas Ab CH-11 for the indicated time points (both of these reagents were used at a final concentration of 0.5 mg/ml). In additional experiments, Jurkat cells were incubated with TAPI and/or various broad-spectrum inhibitors of serine, cysteine, or aspartate proteases (leupeptin, 100 mM; 6-aminocaproic acid, 10 mM; APMSF-HCl, 50 mM; aprotinin, 20 mg/ml; pepstatin A, 3 mM; chymostatin, 20 mM) for 30 min, and then treated with anti-Fas Ab CH-11 for the indicated time points. The working concentrations of these inhibitors were based on those frequently used in the literature (http://sciencegateway.org/resources/protease.htm).
For expression of shRNA in Jurkat cells, the human ADAM17 sequence 59-GCTTGATTCTTTGCTCTCA-39, which was determined to knock down ADAM17 expression, or the ADAM17 sequence 59-CAGCAGCTGGAGT-CCTGTG-39, which did not knock-down ADAM17 expression and was used as a control to assess off-target effects, were followed by a 9 nucleotide noncomplementary spacer (TTCAAGAGA). With their respective reverse complement sequences, the dsDNA constructs were inserted into the pLL3.7 lentiviral vector (Addgene, Cambridge, MA), per the manufacture's instructions, after vector digestion with XhoI and HpaI (New England Biolabs, Ipswich, MA). Lentivirus generation and transduction were performed as previously described (14, 17) .
Flow cytometry and ELISA
For cell staining, Fc receptor and nonspecific Ab binding sites were blocked, and cells were stained with particular mAbs as previously described (8, 27) . Mouse bone marrow leukocytes were triple stained with anti-Gr-1, antimouse L-selectin or anti-LFA-1, and annexin V. For cell staining that involved annexin V (for labeling of externalized phosphatidylinositol) or FLICA (labeling of active caspases), nonfixed cells were used; after their staining with Abs, the cells were treated with either reagent (per the respective manufactures' instructions) and immediately examined by flow cytometry, as previously described (23) . ADAM17 and ADAM10 are typically expressed at low levels; therefore, so staining on Jurkat cells was amplified by treating cells with an anti-ADAM17 or anti-ADAM10 mAb, biotin-conjugated F(ab9) 2 goat anti-mouse IgG, and then allophycocyaninconjugated streptavidin. Isotype-matched negative control mAbs were used to evaluate levels of nonspecific staining. All stained cells were analyzed on a FACSCanto instrument (Becton Dickinson, San Jose, CA).
Soluble murine or human L-selectin in tissue culture media supernatants were quantified by ELISA, as previously described (8, 17) . In some cases, media supernatants were filtered (0.22 mm pore size) then centrifuged at 100,000 3 g before ELISA.
Results
ADAM17 cleaves L-selectin upon the induction of apoptosis
Upon induction of apoptosis, human neutrophils downregulate their surface L-selectin in a manner involving metalloproteinases (23) . L-selectin is shed by ADAM17 following neutrophil activation (8); however, recent studies have revealed that other sheddases can also cleave L-selectin (28) (29) (30) . To directly establish the role of ADAM17 in L-selectin shedding during death receptor-induced apoptosis, we examined murine neutrophils lacking functional ADAM17. Because important differences can occur between human and murine neutrophils (31), we initially established the effects of induced apoptosis by murine neutrophils on their expression of L-selectin. Our primary means of inducing apoptosis by isolated human neutrophils has been through the Fas receptor (23), because of its well established signaling cascades and its direct manner of caspase activation (32) . However, our Fas-binding reagents for human leukocytes (see below) demonstrated little activity with murine neutrophils (data not shown). Instead, TNFa in the presence of cycloheximide was used, which is a reproducible method for inducing neutrophil apoptosis (33) (34) (35) (36) . Murine TNFa was initially titered down to a concentration that induced nominal L-selectin shedding via neutrophil activation during the timeframe of our assays. We observed that our source of TNFa at 5 mg/ml had little effect on phosphatidylserine exposure and L-selectin shedding by murine neutrophils, whereas when combined with cycloheximide, both events were markedly enhanced ( Fig. 1 ). L-selectin surface expression was downregulated in a relatively rapid manner and typically occurred before appreciable reactivity by annexin V with the neutrophils, as determined by flow cytometry. In Figs. 1 and 2, the two events were evaluated at different time points. The downregulation in L-selectin surface expression and production of its soluble extracellular fragment were consistently observed in our assays by 90 min after the induction of apoptosis (Fig. 1) ; and at this time point, soluble L-selectin production was essentially abolished by broad-spectrum zinc metalloprotease inhibitors, such as TAPI (Fig. 1) . Such inhibitors, however, did not prevent the cells from undergoing apoptosis, as previously described for human neutrophils (23) .
Targeting the Adam17 gene in all cells of mice is lethal, and most die soon after birth (7). However, radiation chimeric mice reconstituted with hematopoietic cells lacking functional ADAM17 (ADAM17 chimeras) are viable (8, 9 ). An assessment of neutrophils from wild-type chimeras (reconstituted with wild-type hematopoietic cells) revealed that they also shed their L-selectin upon the induction of apoptosis by TNFa/cycloheximide, as determined by flow cytometry and ELISA ( Fig. 2A) . In contrast to these cells, the shedding of L-selectin by neutrophils from ADAM17 chimeras was quite minimal at early time points of induced apoptosis ( Fig. 2A) . Neutrophils from both chimeras demonstrated similar levels of phophatidylserine exposure after their treatment with TNFa/cycloheximide ( Fig. 2A) , indicating that a lack of functional ADAM17 did not prevent the apoptotic process.
ADAM8 has also been implicated in L-selectin shedding by activated neutrophils (29) ; therefore, we examined its contribution in the shedding of L-selectin by apoptotic neutrophils as well. This was done in a direct manner by using neutrophils obtained from ADAM8 knockout mice. In contrast to ADAM17-deficient neutrophils, however, we observed that ADAM8-deficient neutrophils efficiently downregulated their surface L-selectin upon their treatment with TNFa/cycloheximide (Fig. 2B) .
We also directly examined the role of ADAM17 in L-selectin shedding by human leukocytes. This was done by using shRNA specific for ADAM17 to knock-down its expression. Targeting ADAM17 in human neutrophils is problematic considering that they are short-lived and that their manipulation by transfection or transduction consistently induced some level of activation, which may confound our results. Instead, Jurkat cells-a human T cell line-were used. The advantages of these cells are that they express high levels of endogenous L-selectin, unlike most human myeloid cell lines, and Jurkat cells are one of the best-studied cell types in regard to Fas-induced apoptosis (37) . We found that the engagement of their Fas receptor led to efficient L-selectin shedding, which was performed by using either soluble recombinant human FasL (rhFasL) or the anti-Fas IgM mAb CH-11 (Supplemental Fig.  1A-C) . As with neutrophils, the induction of L-selectin shedding by Jurkat cells occurred as an early apoptotic event before phosphatidylserine exposure (Supplemental Fig. 1A ). The treatment of Jurkat cells with rhFasL consistently induced L-selectin shedding and phosphatidylserine exposure more rapidly than did CH-11 treatment (data not shown), which may be related to different manners of Fas engagement.
Jurkat cells were transduced with a bicistronic lentivirus vector that expressed GFP and ADAM17 shRNA in a proportional manner. Greater than 50% of the transduced Jurkat cells expressed GFP, and the GFP-positive cells expressed ∼50% less cell surface ADAM17 than the GFP-negative cells (Fig. 3A) , whereas surface ADAM10 expression, the ADAM family member most similar to ADAM17 (38), was equivalent for both populations (Fig. 3A) . Control ADAM17 shRNA was observed to have no effect on the surface levels of ADAM17 expression (Fig. 3A) . Following the treatment of Jurkat cells transduced with active ADAM17 shRNA with rhFasL, L-selectin surface expression downregulated to a greater extent by GFP-negative cells than by GFP-positive cells (Fig. 3B) . When the transduced cells were treated with TAPI before the induction of apoptosis, L-selectin shedding by the GFPnegative cells was blocked, demonstrating that the downregulation of L-selectin occurred by ectodomain shedding (Fig. 3B) . These findings reveal ADAM17 activity upon the induction of leukocyte apoptosis, and that it is the primary sheddase of L-selectin during this process.
Soluble L-selectin is produced at later stages of induced leukocyte apoptosis independent of ADAM17 When monitoring L-selectin shedding by Jurkat cells undergoing induced apoptosis in the presence of TAPI over an extended period, we noted that although initially blocked, considerable production of soluble L-selectin did occur at later time points. As shown in Fig.  4A , soluble L-selectin production was assayed for up to 4 h by Jurkat cells that were either untreated, treated with CH-11, or treated with CH-11 and TAPI. Two hours after the induction of apoptosis, high levels of soluble L-selectin were detected, which was essentially abolished by the presence of TAPI. At the 3 and FIGURE 2. ADAM17, but not ADAM8, mediates L-selectin shedding at early time points of induced apoptosis. A, Mouse bone marrow-derived neutrophils (2 3 10 6 per ml) from wild-type chimeras or ADAM17 chimeras were either untreated or treated with TNFa or TNFa and CHX for 90 min (panels marked L-selectin) or for 180 min (panels marked annexin-V) at 37˚C. B, Mouse bone marrow-derived neutrophils (2 3 10 6 per ml) from ADAM8 knockout mice were treated as described above. Relative Lselectin surface expression levels and annexin-V reactivity were determined by flow cytometry, and data shown are representative of at least three independent experiments using neutrophils isolated from separate animals. Negative control Ab staining of untreated cells is indicated (Isotype). The x-axis = Log 10 fluorescence. Soluble L-selectin levels in the media supernatants were determined by ELISA, and data shown are the mean 6 SD of three independent experiments performed in duplicate. /ml) were either untreated or treated with TNFa, TNFa and cycloheximide (CHX), or TNFa, CHX, and TAPI. The cells were cultured at 37˚C for 90 min before L-selectin detection and for 180 min before phosphatidylserine detection. Relative L-selectin surface expression levels and annexin V reactivity were determined by flow cytometry, as described in Materials and Methods. Data shown are representative of at least three independent experiments using neutrophils isolated from separate animals. Negative control Ab staining of untreated cells is indicated (Isotype). The x-axis = Log 10 fluorescence. To assess soluble L-selectin levels, neutrophils (4 3 10 6 per ml) were treated as described above for 90 min at 37˚C, and media supernatants from the respective samples were subjected to ELISA, as described in Materials and Methods. The ELISA data are the mean 6 SD of three independent experiments performed in duplicate. 4 h time points, however, apoptotic Jurkat cells in the presence of TAPI produced significantly higher levels of soluble L-selectin than time-matched, untreated cells (Fig. 4A) . At these later time points of apoptosis, cell surface L-selectin also underwent a corresponding downregulation in expression in the presence of TAPI (Fig. 4B ). This late apoptotic process did not result in a general downregulation in the expression of cell surface molecules, as the surface levels of LFA-1 on the same cells were only modestly decreased (Fig. 4B) . We also monitored ADAM17 surface expression on Jurkat cells at various time points of apoptosis. Jurkat cells treated with CH-11 for 2 h demonstrated surface ADAM17 expression levels equivalent to time-matched, untreated cells, whereas cells treated for with CH-11 for 4 h demonstrated a marginal decrease in ADAM17 staining when compared with time-matched, untreated cells. Hence, soluble L-selectin production occurred at later stages of apoptosis in the presence of a broad-spectrum metalloprotease inhibitor and during the downregulation of ADAM17 surface expression.
An obvious consideration for assays involving TAPI is its stability during extended cell incubation periods. We examined this in a cell-based assay by collecting media supernatants from Jurkat cells treated with CH-11 for 4 h in the presence or absence of TAPI, and using the media supernatants to suspend untreated Jurkat cells, which were then overtly activated with PMA to induce L-selectin shedding. We found that activated Jurkat cells incubated in media supernatant from the CH-11/TAPI-treated cells did not downregulate their expression of surface L-selectin, whereas Jurkat cells incubated in media supernatant from the CH-11-treated cells did (Fig. 4C) , indicating activity by the metalloprotease inhibitor. We have also added TAPI to Jurkat cells in culture prior to and at regular time points after the induction of apoptosis, and again noted a significant downregulation in L-selectin expression at the later time points of apoptosis (data not shown).
In addition to a broad-spectrum metalloprotease inhibitor, we examined the effects of other protease inhibitors on the late apoptosis release of soluble L-selectin, in particular inhibitors of serine proteases, which can also cleave L-selectin and have been implicated in ectodomain shedding (39-41). As shown in Supplemental Fig. 2 , Jurkat cells treated with TAPI to block the initial shedding of L-selectin during the induction of apoptosis with various other broad-spectrum protease inhibitors produced levels of soluble L-selectin similar to those in cells treated with TAPI alone.
Membrane blebbing and microparticle production are additional mechanisms by which certain surface proteins can be downregulated during leukocyte apoptosis. Interestingly, CD43 and CD16, which undergo ectodomain shedding upon neutrophil activation (42), can be downregulated in expression during neutrophil apoptosis by these processes (43, 44) . To determine whether L-selectin released from the surface of Jurkat cells treated with CH-11 and TAPI was associated with membrane particles, the particles were removed from the media supernatant by filtration and ultracentrifugation. For example, media supernatant from Jurkat cells treated with CH-11 and TAPI for 4 h was divided into two equal volumes, and one of the aliquots was filtered (0.22 mm pore size) then centrifuged at 100,000 3 g for 1 h. Soluble L-selectin levels in the two aliquots were then compared by ELISA. If soluble L-selectin produced by apoptotic Jurkat cells in the presence of TAPI was primarily associated with membrane particles, we would expect that its levels would be significantly decreased after the described treatments; however, this was not the case (Fig. 4D) .
Soluble L-selectin occurs at high levels in the blood of healthy humans and mice (45, 46) . Interestingly, the levels of soluble L-selectin in the blood of ADAM17 and wild-type chimeric mice are not significantly different (8) , suggesting another mechanism for its production. As with Jurkat cells, we observed that murine neutrophils also downregulated their surface L-selectin at later time points of induced apoptosis in the presence of TAPI. For instance, by 3 h of induced apoptosis, neutrophils from unmanipulated mice treated with TNFa/cycloheximide in the presence of TAPI demonstrated an appreciable downregulation in L-selectin expression, as determined by flow cytometry (Fig. 5A) . Again, surface levels of LFA-1 on the same cells decreased only marginally at this time point (Fig. 5A) . In contrast to early time points following the induction of apoptosis, neutrophils isolated from ADAM17 chimeras also demonstrated a downregulation in surface L-selectin expression as apoptosis progressed (Fig. 5B) , resulting in a corresponding increase in soluble L-selectin levels (Fig. 5C) . The above findings reveal that soluble L-selectin production can occur by distinct mechanisms invoked at different stages of induced apoptosis.
Discussion
Emerging evidence indicates that ectodomain shedding by leukocytes is a key posttranslational mechanism for regulating inflammation. In part, this process modulates the activity of various cytokines, cytokine receptors, and adhesion molecules (5). ADAM17 induction occurs upon cell activation, and its biological functions have been mainly examined in this context. The fate of neutrophils following their infiltration into sites of inflammation is programmed cell death, which is an effector activity that plays a vital role in resolving acute inflammation (20, 21) . In this study, we provide the first direct evidence that ADAM17 cleaves L-selectin upon the induction of neutrophil apoptosis, which appears to be an early apoptotic event. We also report that as the apoptotic process progresses, L-selectin can be released from the surface of leukocytes by a mechanism distinct from ADAM17-mediated shedding and the membrane events of blebbing and microparticle production.
We have previously reported that L-selectin undergoes efficient shedding upon the induction of human neutrophil apoptosis by a mechanism that involves metalloproteases (23) . L-selectin shedding has been reported to occur in an ADAM17-dependent and independent manner (8, 28-30); therefore, we directly examined its role in L-selectin shedding upon death receptor-induced leukocyte apoptosis by using two distinct genetic approaches. Fas signaling of apoptosis in Jurkat cells has been extensively studied (37) , and these cells, which express high levels of surface L-selectin, were used to knock down ADAM17 expression using shRNA. This approach decreased the expression of cell surface ADAM17, but not the expression of its most similar family member ADAM10, and also reduced L-selectin shedding upon Fas engagement when compared with control cells. We also examined the shedding of L-selectin by neutrophils lacking functional ADAM17 following the induction of apoptosis. In contrast to wild-type neutrophils, ADAM17-deficient neutrophils demonstrated a near complete abrogation of L-selectin shedding at early time points of induced apoptosis. ADAM8 has been implicated in L-selectin shedding by neutrophils as well (29), and we also directly examined its role by using neutrophils from ADAM8 knockout mice. We observed that these cells efficiently downregulated their surface L-selectin expression soon after the induction of apoptosis. Hence, our findings indicate that in addition to neutrophil activation, ADAM17 is a primary sheddase of L-selectin upon death receptor-induced apoptosis.
Activation-induced L-selectin shedding regulates the receptor's cell surface density and neutrophil adhesiveness (18, 47) . The purpose of L-selectin shedding during neutrophil apoptosis is less clear at this time, although receptor downregulation by apoptotic neutrophils likely contributes to a general diminution in their -D) . The x-axis = Log 10 fluorescence. E, Jurkat cells were incubated in the absence or presence of the anti-Fas Ab CH-11 plus TAPI, as indicated, for 4 h at 37˚C. The tissue culture media supernatant from both cell treatments was divided into two equal aliquots, and one of the aliquots was subjected to filtration (0.22 mm) then ultracentrifugation (100,000 3 g) for 1 h. The levels of soluble L-selectin in the two aliquots for both cell treatments were determined by ELISA. B-D, data are representative of at least three independent experiments. Data in A and E are the mean 6 SD of three independent experiments performed in duplicate. Statistical significance was determined by an unpaired Student t test. pp , 0.001 versus untreated; ppp , 0.05 versus untreated.
The Journal of Immunologyresponsiveness to inflammatory cues (22) . Neutrophils that have recently infiltrated sites of inflammation already express low levels of L-selectin because of their activated state (8, 18, 48) ; therefore, it would seem that nominal levels of cell surface L-selectin would be available for further ADAM17-mediated cleavage upon the induction of neutrophil apoptosis. However, activated neutrophils express L-selectin mRNA, actively synthesize the adhesion molecule, and can re-express appreciable levels of surface L-selectin following their activation, but prior to undergoing apoptosis (23) (49, 50) . Consequently, ADAM17-mediated shedding during neutrophil apoptosis at sites of inflammation may produce physiologically relevant levels of localized soluble L-selectin, among additional substrates. Other settings in which ADAM17-dependent shedding may occur upon leukocyte apoptosis is during the clearance of senescent neutrophils from the blood and the turnover of lymphocytes during negative selection, which may be a mechanism for the downregulation of various receptors and/or the production of assorted soluble agonists and antagonists. The enzymatic activity of ADAM17 is robustly induced upon cell activation with various stimuli, which occurs in part through an intrinsic process (51, 52) . We speculate that the enzymatic activity of ADAM17 is enhanced upon the induction of leukocyte apoptosis as well, although at this time we cannot rule out that changes in the conformation of L-selectin and/or its cell surface distribution might also contribute to its shedding during this cellular process. We have recently reported that redox modifications of cysteinyl sulfhydryl groups in the ectodomain of mature ADAM17 upregulates its enzymatic activity (14) . It will be interesting to determine whether this inducer mechanism might also regulate the activity of ADAM17 upon death receptor-induced neutrophil apoptosis. In addition, increased conversion of ADAM17's proform to mature form has also been reported during leukocyte apoptosis (53) .
Our data also reveal that during the late stages of neutrophil apoptosis, L-selectin expression can be downregulated by a mechanism distinct from ADAM17, which results in the production of soluble L-selectin. CD16 and CD43 can undergo ectodomain shedding as well upon neutrophil activation, and they have been reported to be released from the surface of neutrophils by membrane blebbing and microparticle production during apoptosis (43, 44 ). An approach used to discern soluble adhesion molecules that are cleaved from those associated with membrane particles is by sedimentation of the latter using ultracentrifugation (44, 54) . We found that a combination of filtration ($0.22 mm particle size) as well as ultracentrifugation (100,000 3 g) did not significantly reduce the levels of soluble L-selectin in the tissue culture media supernatant from cells undergoing prolonged apoptosis in the presence of the broad spectrum zinc metalloprotease inhibitor TAPI, suggesting that it may have been produced by a proteolytic process.
ADAM10 has been reported to cleave L-selectin in the absence of its primary sheddase ADAM17 (30) . However, it would seem unlikely that ADAM10 is playing a major role in soluble L-selectin production by apoptotic leukocytes, considering that it has been shown to downregulate in expression during this process (23) , and that soluble L-selectin production occurred in the presence of TAPI, which is known to block ADAM10 activity (55) (56) (57) . Serine proteases have been implicated as sheddases and can also cleave L-selectin (39) (40) (41) . However, we show that various broadspectrum serine protease inhibitors, as well as inhibitors of aspartic and cysteine proteases, also did not block soluble L-selectin production by late apoptotic leukocytes. Thus, the precise proteolytic process by which soluble L-selectin production occurs during later stages of leukocyte apoptosis remains to be determined. In addition, it will be interesting to determine whether this putative protease targets other cell surface determinants. For example, surface expression of PSGL-1, a ligand of L-selectin (58), can also be downregulated during neutrophil apoptosis, which appears to involve a non-ADAM17 proteolytic process as well (54) .
The current study is the first to establish mechanisms of soluble L-selectin production upon death receptor-induced, neutrophil apoptosis. We have previously reported that ADAM17-deficient neutrophils can generate soluble L-selectin upon spontaneous apoptosis, which appears to involve other metalloproteases (8) . The biologic significance of ADAM17-independent processes that mediate the release of surface L-selectin from apoptotic neutrophils is unclear at this time. Soluble L-selectin is maintained at high levels in the blood of healthy individuals and mice (45, 46) . We have reported that the levels of soluble L-selectin in the blood of ADAM17 and wild-type chimeric mice are not significantly different (8) , suggesting that ADAM17 might not be the principle means of maintaining blood levels of soluble L-selectin. However, Venturi et al. (18) have reported that soluble L-selectin in the blood is primarily derived by proteolytic cleavage, as gene-targeted mice expressing noncleavable L-selectin have considerably lower levels of serum L-selectin. In conjunction with our findings, it is tempting to speculate that soluble L-selectin levels in the blood of normal individuals may be maintained by a proteolytic mechanism other than ADAM17, perhaps occurring during leukocyte apoptosis. 6 per ml) were either untreated or treated with TNFa or TNFa/CHX in the presence or absence of TAPI for 180 min at 37˚C. B, Mouse bone marrow-derived neutrophils (2 3 10 6 per ml) from ADAM17 chimeras were either untreated or treated with TNFa or TNFa/CHX for 180 min at 37˚C. A and B, Relative L-selectin or LFA-1 surface expression levels and annexin-V reactivity were determined by flow cytometry. Negative control Ab staining of untreated cells is indicated (Isotype). The x-axis = Log 10 fluorescence. Data are representative of at least three independent experiments using neutrophils isolated from separate animals. C, Mouse bone marrow-derived neutrophils (2 3 10 6 per ml) from ADAM17 chimeras were either untreated or treated with TNFa/CHX at 37˚C for the indicated time points. The presence of soluble L-selectin in the cell supernatants was determined by ELISA. Data are represented as the mean 6 SD of three independent experiments performed in duplicate.
In conclusion, ADAM17 appears to be active during the various phases of a neutrophil's short life span, such as during their time in circulation (e.g., maintains L-selectin at an appropriate cell surface density) (8) , upon their activation (8) , and during death receptor-mediated apoptosis. The induction of ectodomain shedding during leukocyte apoptosis likely has a much broader purpose than just cleaving L-selectin. Indeed, various leukocyte determinants that undergo ectodomain shedding have an important role in regulating the resolution of inflammation, including TNFa, TNFRI, TNFRII, FasL, TRAIL, and IL-6R (53, (59) (60) (61) (62) (63) ; therefore, this process may be another component of the anti-inflammatory program initiated by neutrophils (20) (21) .
